Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

Abroad (travel likely)Recruiting

Conditions

Acute Coronary Syndrome · Continuous Glucose Measurement · Glycemic Variability · Cardiovascular Event

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital of Béziers, Béziers, France
Contact: Study coordinator (Frédéric GEORGER, MD) · 0467357134
Contact: Study coordinator (Jean-Michel ANDRIEU, MD) · 0467357636
Contact: Principal Investigator (Frédéric GEORGER)
University Hospital of Bordeaux, Bordeaux, France
Contact: Study coordinator (Edouard GERBAUD, MD) · edouard.gerbaud@chu-bordeaux.fr · 0557656446
Contact: Study coordinator (CATARGI Bogdan Nicolescu, MD) · bogdan.catargi@chu-bordeaux.fr
Contact: Principal Investigator (Edouard GERBAUD)
University Hospital of Montpellier, Montpellier, France
Contact: Study coordinator (François ROUBILLE, PU-PH) · f-roubille@chu-montpellier.fr · 0467335953
Contact: Study coordinator (Ariane SULTAN, PU-PH) · a-sultan@chu-montpellier.fr · 0467338402
Contact: Principal Investigator (Ariane SULTAN)
François ROUBILLE (Sub-investigator)
University Hospital of Nîmes, Nîmes, France
Contact: Study coordinator (Benoît LATTUCA, Pr) · 0466683116
Contact: Study coordinator (Véronique TAILLARD, Dr) · 0466683321
Contact: Principal Investigator (Benoît LATTUCA)
AP-HP Lariboisière Hospital, Paris, France
Contact: Study coordinator (Patrick HENRI, Pr) · patrick.henry@aphp.fr · 0149959017
Contact: Study coordinator (Jean François GAUTHIER, Pr) · jean-francois.gauthier@aphp.fr · 0149959020
Contact: Principal Investigator (Patrick HENRI)
APHP - Hôpital Européen Georges Pompidou, Paris, France
Contact: Study coordinator (PUYMIRAT Etienne, MD) · etienne.puymirat@aphp.fr · 0156092851
Contact: Principal Investigator (PUYMIRAT Etienne, MD)
Hospital of Pau, Pau, France
Contact: Study coordinator (Pierre POUSTIS, MD) · 0559924878
Contact: Study coordinator (Christel VOINOT, MD) · 0559727301
Contact: Principal Investigator (Nicolas DELARCHE)
University Hospital of Toulouse, Toulouse, France
Contact: Study coordinator (Meyer ELBAZ, Pr) · elbaz.m@chu-toulouse.fr · 0561323649
Contact: Study coordinator (Pierre GOURDY, Pr) · pierre.gourdy@inserm.fr · 0561323740
Contact: Principal Investigator (Meyer ELBAZ)
Vannes Bretagne Atlantique Hospital, Vannes, France
Contact: Study coordinator (HUET Fabien, MD) · fabien.huet@ch-bretagne-atlantique.fr · 0297416727
Contact: Study coordinator (ARNAULT Gwénaëlle, MD) · gwenaelle.arnault@ch-bretagne-atlantique.fr
Contact: Principal Investigator (HUET Fabien, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Acute Coronary Syndrome · Hyperlipidemias · Percutaneous Coronary Intervention

Abroad (travel likely)Recruiting

Nanjing, China

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Coronary Artery Disease · Percutaneous Coronary Intervention · Acute Coronary Syndrome

Abroad (travel likely)RecruitingPHASE4

Anyang, South Korea · Bucheon-si, South Korea

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome

Abroad (travel likely)RecruitingPHASE3

Alexander City, United States · Birmingham, United States

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Tuberculosis · Acute Coronary Syndrome · Pulmonary Hypertension (Diagnosis)

Abroad (travel likely)RecruitingPHASE3

Kota Kinabalu, Malaysia · Kota Kinabalu, Malaysia